PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PLTR vs. DNA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


PLTRDNA
YTD Return31.16%-49.11%
1Y Return187.98%-27.11%
3Y Return (Ann)-1.94%-56.34%
Sharpe Ratio2.71-0.31
Daily Std Dev70.51%89.72%
Max Drawdown-84.62%-94.79%
Current Drawdown-42.26%-94.24%

Fundamentals


PLTRDNA
Market Cap$45.29B$1.86B
EPS$0.09-$0.46
Revenue (TTM)$2.23B$251.46M
Gross Profit (TTM)$1.50B$273.49M
EBITDA (TTM)$153.32M-$662.28M

Correlation

-0.50.00.51.00.5

The correlation between PLTR and DNA is 0.54, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

PLTR vs. DNA - Performance Comparison

In the year-to-date period, PLTR achieves a 31.16% return, which is significantly higher than DNA's -49.11% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%60.00%80.00%NovemberDecember2024FebruaryMarchApril
49.42%
-36.28%
PLTR
DNA

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Palantir Technologies Inc.

Ginkgo Bioworks Holdings, Inc.

Risk-Adjusted Performance

PLTR vs. DNA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Palantir Technologies Inc. (PLTR) and Ginkgo Bioworks Holdings, Inc. (DNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PLTR
Sharpe ratio
The chart of Sharpe ratio for PLTR, currently valued at 2.71, compared to the broader market-2.00-1.000.001.002.003.004.002.71
Sortino ratio
The chart of Sortino ratio for PLTR, currently valued at 3.66, compared to the broader market-4.00-2.000.002.004.006.003.66
Omega ratio
The chart of Omega ratio for PLTR, currently valued at 1.44, compared to the broader market0.501.001.501.44
Calmar ratio
The chart of Calmar ratio for PLTR, currently valued at 2.57, compared to the broader market0.002.004.006.002.57
Martin ratio
The chart of Martin ratio for PLTR, currently valued at 12.51, compared to the broader market0.0010.0020.0030.0012.51
DNA
Sharpe ratio
The chart of Sharpe ratio for DNA, currently valued at -0.31, compared to the broader market-2.00-1.000.001.002.003.004.00-0.31
Sortino ratio
The chart of Sortino ratio for DNA, currently valued at 0.12, compared to the broader market-4.00-2.000.002.004.006.000.12
Omega ratio
The chart of Omega ratio for DNA, currently valued at 1.01, compared to the broader market0.501.001.501.01
Calmar ratio
The chart of Calmar ratio for DNA, currently valued at -0.29, compared to the broader market0.002.004.006.00-0.29
Martin ratio
The chart of Martin ratio for DNA, currently valued at -0.74, compared to the broader market0.0010.0020.0030.00-0.74

PLTR vs. DNA - Sharpe Ratio Comparison

The current PLTR Sharpe Ratio is 2.71, which is higher than the DNA Sharpe Ratio of -0.31. The chart below compares the 12-month rolling Sharpe Ratio of PLTR and DNA.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
2.71
-0.31
PLTR
DNA

Dividends

PLTR vs. DNA - Dividend Comparison

Neither PLTR nor DNA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

PLTR vs. DNA - Drawdown Comparison

The maximum PLTR drawdown since its inception was -84.62%, smaller than the maximum DNA drawdown of -94.79%. Use the drawdown chart below to compare losses from any high point for PLTR and DNA. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-21.72%
-94.24%
PLTR
DNA

Volatility

PLTR vs. DNA - Volatility Comparison

The current volatility for Palantir Technologies Inc. (PLTR) is 10.73%, while Ginkgo Bioworks Holdings, Inc. (DNA) has a volatility of 23.35%. This indicates that PLTR experiences smaller price fluctuations and is considered to be less risky than DNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%35.00%NovemberDecember2024FebruaryMarchApril
10.73%
23.35%
PLTR
DNA

Financials

PLTR vs. DNA - Financials Comparison

This section allows you to compare key financial metrics between Palantir Technologies Inc. and Ginkgo Bioworks Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items